Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology

Journal of hematology and oncology, 2022-01, Vol.15 (1), p.5-5, Article 5 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-021-01222-y ;PMID: 35012610

Full text available